Is Excedrin Safe During Pregnancy

Reason

Contains aspirin, an NSAID. FDA advises avoiding NSAIDs at 20 weeks or later in pregnancy unless directed by a clinician.

Drug Information

Brand Name

Excedrin

Generic Name

acetaminophen + aspirin + caffeine

Drug Class

analgesic combination (acetaminophen, NSAID salicylate, methylxanthine)

FDA Category

N/A (PLLR narrative label)

Rx Status

OTC

Safe Amount

Dosage must be determined by your provider based on individual risk/benefit.

Effects

Pregnancy

Avoid routine use in pregnancy, especially after 20 weeks; use only if a clinician says it is needed.

Mother

May increase bleeding risk and can complicate delivery, especially later in pregnancy.

Baby

May cause low amniotic fluid and rare fetal kidney problems after 20 weeks. Near 30 weeks, may cause fetal heart and circulation problems.

Trimester Notes

1st Trimester

Use only if a clinician says it is needed. Limited pregnancy-specific data for this combination.

2nd Trimester

Avoid routine use. FDA warns against NSAIDs at 20 weeks or later unless directed by a clinician.

3rd Trimester

Avoid. NSAIDs can affect the baby’s heart and circulation near 30 weeks and may increase delivery complications.

Conditions & Warnings

• Consult OB/GYN or prescriber
• If pregnant and using regularly, ask before continuing
• Pregnancy dosing limits may apply
• Avoid use after 20 weeks unless a clinician directs it

Alternatives

• acetaminophen alone only if your clinician approves
• non-medicine measures such as rest, fluids, and trigger avoidance
• ask your OB/GYN or pharmacist for a pregnancy-appropriate option

References

• FDA: NSAIDs in pregnancy safety communication
  https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-avoiding-use-nsaids-pregnancy-20-weeks-or-later-because-they-can-result-low-amniotic
• FDA/DailyMed labeling warning for aspirin-containing products
  https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/020802Orig1s040lbl.pdf